Searched for
TARO STAKE BUYOUT
Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...- Taro stake buyout to help operate its dermatology biz profitably amid enhanced competition: Sun PharmaThe company has issued a letter to the Taro board with a proposal containing a non-binding indication of interest to acquire all of the out...
- Taro stake buyout to help operate its dermatology biz profitably amid enhanced competition: Sun PharmaSun Pharma is looking to fully acquire its Israel-based unit Taro Pharmaceutical Industries in order to integrate the dermatology business ...
- Toshiba shareholders vote down both spin-off plan and call to seek buyout offersThe proposal to seek private equity buyout offers or a minority investment was made by Singapore-based 3D Investment Partners, Toshiba's No...
- Toshiba shareholders vote down both spin-off plan and call to seek buyout offersThe result of the extraordinary general meeting will likely force Toshiba to revise its controversial restructuring plan and ensure that th...
- Top 10 winners and losers on Street as Modi completes one year in powerIn the one year that Narendra Modi has been the prime minister of India, the stock market has seen sharp swings.
- Sun Pharmaceutical acquires ailing Ranbaxy Laboratories for $4 billionFollowing the acquisition, the Ranbaxy brand will cease to exist and both the companies will be operated under one management.
- Dose of bitter pills, few booster injections for pharma sectorThe pharma sector, estimated to be around Rs 1.5 lakh cr, recorded single digit growth for the first time in many years on account of deepe...
- Cipla puts Medpro buyout on hold over valuation issuesCipla decides to put on hold its $220-million acquisition plan of the third-largest South African drugmaker Cipla Medpro due to valuation i...
- Sun Pharma drops plan to buy out Taro’s minority shareholdersSun Pharma had acquired majority stake (66%) in the Israeli generic firm Taro Pharma in 2007 for $450 million, but got control of the compa...
- Stocks from 9 sectors that could outperform peers in 2013ET identifies 2 stocks each from 9 sectors that could outperform peers. Their ability to grow make them our preferred picks.
- Taro postpones shareholders meeting on merger with Sun PharmaIsraeli firm Taro Pharmaceutical Industries Ltd said it postponed a meeting of shareholders to consider the company's proposed merger with ...
- Taro Pharma shareholder rejects Sun Pharma's revised offerA minority shareholder of Taro Pharma on Monday rejected Sun Pharma's sweetened offer price of $39.5 a share for a buyout, signalling furth...
- Ten stocks in focus in Tuesday morning tradeHere is a list of ten stocks that are likely to be in action in morning trade today.
- Taro Pharmaceuticals' excellent Q4 performance may kill Sun Pharma buyoutSun Pharma's proposed buyout of Taro Pharmaceuticals might have been "killed" by the Israeli company's exceptional Q4 performance, said med...
- Stocks to watch: ONGC, HCL, Satyam, Glaxo, Sun PharmaStocks are likely to remain in a trading range with bouts of profit booking ahead of India Inc's earnings season commencement next week.
- A new sun rises on Shanghvi's profit strategyDilip Shanghvi, the chairman and managing director of Sun Pharmaceuticals, has little in common with Yogi Berra.
Load More
